7733 logo

Olympus Corporation Stock Price

TSE:7733 Community·JP¥2.1t Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author
Create a narrative

7733 Share Price Performance

JP¥1,872.00
-928.50 (-33.15%)
37.6% undervalued intrinsic discount
JP¥3,001.00
Fair Value
JP¥1,872.00
-928.50 (-33.15%)
45.1% undervalued intrinsic discount
JP¥3,411.90
Fair Value
Price JP¥1,872.00
AnalystHighTarget JP¥3,411.90
AnalystConsensusTarget JP¥2,006.43
AnalystLowTarget JP¥1,825.00

7733 Community Narratives

AnalystHighTarget·
Fair Value JP¥3k 37.6% undervalued intrinsic discount

Digital And Robotic Endoscopy Will Serve A Growing Aging Market

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value JP¥2.01k 6.7% undervalued intrinsic discount

Reorganization And OLYSENSE Launch Will Improve Efficiency And Market Share

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AnalystLowTarget·
Fair Value JP¥1.66k 12.8% overvalued intrinsic discount

Austerity Policies And FDA Alerts Will Trigger Price Erosion

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Recent 7733 News & Updates

Olympus (TSE:7733) Might Have The Makings Of A Multi-Bagger

Sep 30
Olympus (TSE:7733) Might Have The Makings Of A Multi-Bagger

Earnings Miss: Olympus Corporation Missed EPS By 50% And Analysts Are Revising Their Forecasts

Aug 12
Earnings Miss: Olympus Corporation Missed EPS By 50% And Analysts Are Revising Their Forecasts

A Look At The Intrinsic Value Of Olympus Corporation (TSE:7733)

Jul 25
A Look At The Intrinsic Value Of Olympus Corporation (TSE:7733)

Subdued Growth No Barrier To Olympus Corporation's (TSE:7733) Price

Jul 09
Subdued Growth No Barrier To Olympus Corporation's (TSE:7733) Price

Olympus (TSE:7733) Seems To Use Debt Quite Sensibly

Jun 17
Olympus (TSE:7733) Seems To Use Debt Quite Sensibly

Olympus Corporation Key Details

JP¥969.0b

Revenue

JP¥306.4b

Cost of Revenue

JP¥662.6b

Gross Profit

JP¥550.6b

Other Expenses

JP¥112.0b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 07, 2025
Earnings per share (EPS)
101.10
Gross Margin
68.38%
Net Profit Margin
11.56%
Debt/Equity Ratio
37.8%

Olympus Corporation Competitors

 
 
 
 
 
 
 
 
 
 
 
 
View more competitors

Snowflake Analysis

Flawless balance sheet with solid track record and pays a dividend.

0 Risks
2 Rewards
View Full Analysis

About 7733

Founded
1919
Employees
29297
CEO
Robert White
WebsiteView website
www.olympus-global.com

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through: Endoscopic Solutions, Therapeutic Solutions Others segments. The company offers gastrointestinal endoscopes, surgical endoscopes, and medical services. It also offers gastroenterology devices, urology products, respiratory products, energy devices, ENT products, gynecology products. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Tokyo, Japan.

Market Insight

Header cover image

✨Rare Earths: Tiny Market, Outsized Influence

Richard Bowman avatarRichard Bowman
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Last Week
⚡ Utilities: Defensive Dividends Meet the AI Power Surge

⚡ Utilities: Defensive Dividends Meet the AI Power Surge

Japanese Market Performance

  • 7 Days: 2.7%
  • 3 Months: 13.4%
  • 1 Year: 18.6%
  • Year to Date: 16.9%
Over the last 7 days, the market has risen 2.7%, driven by gains of 7.2% in the Information Technology sector. As for the past 12 months, the market is up 19%. As for the next few years, earnings are expected to grow by 8.1% per annum. Market details ›